These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 320473)

  • 1. Serum factors and T lymphocytes in Hodgkin's disease: correction.
    N Engl J Med; 1977 Mar; 296(11):630. PubMed ID: 320473
    [No Abstract]   [Full Text] [Related]  

  • 2. Letter: In-vitro restoration by levamisole of thymus-derived lymphocyte functions in Hodgkin's disease.
    Verhaegen H; De Cock W; De Cree J; Verbruggen F; Verhaegen-Declercq M; Brugmans J
    Lancet; 1975 Apr; 1(7913):978. PubMed ID: 48151
    [No Abstract]   [Full Text] [Related]  

  • 3. Letter: In-vitro resotration by levamisole of thymus-derived lymphocyte function in Hodgkin's disease.
    Biniaminov M; Ramot B
    Lancet; 1975 Feb; 1(7904):464. PubMed ID: 48661
    [No Abstract]   [Full Text] [Related]  

  • 4. Restoration of cellular immune response by levamisole in patients with Hodgkin's disease.
    Levo Y; Rotter V; Ramot B
    Biomedicine; 1975 Jun; 23(6):198-200. PubMed ID: 1082352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional evaluation of T-lymphocytes from peripheral blood and spleens in Hodgkin's disease.
    Mukhopadhyaya R; Advani SH; Gangal SG
    Br J Cancer; 1987 Dec; 56(6):800-2. PubMed ID: 2829954
    [No Abstract]   [Full Text] [Related]  

  • 6. Letter: Lymphocytes in spleen in Hodgkin's disease.
    Grifoni V; Del Giacco GS; Manconi PE; Tognella S; Mantovani G
    Lancet; 1975 Feb; 1(7902):332-3. PubMed ID: 46472
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of levamisole on E-rosette-forming cells in vivo and in vitro in Hodgkin's disease.
    Ramot B; Biniaminov M; Shoham C; Rosenthal E
    N Engl J Med; 1976 Apr; 294(15):809-11. PubMed ID: 1082545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction between serum factors and T lymphocytes in Hodgkin's disease. Use as a diagnostic test.
    Fuks Z; Strober S; Kaplan HS
    N Engl J Med; 1976 Dec; 295(23):1273-8. PubMed ID: 185517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The character and function of mononuclear cells in the spleen and peripheral blood in Hodgkin's disease].
    Pick AI; Loven D; Douer D; Kessler H; Weiss H; Duczyminer M; Har-Zahav L
    Harefuah; 1980; 98(10):433-7. PubMed ID: 7005036
    [No Abstract]   [Full Text] [Related]  

  • 10. Lymphocytes bearing surface ferritin in patients with Hodgkin's disease and breast cancer.
    N Engl J Med; 1977 May; 296(20):1172-4. PubMed ID: 323704
    [No Abstract]   [Full Text] [Related]  

  • 11. [Disorders of cellular immunity in Hodgkin's disease].
    Burchardt K
    Pol Arch Med Wewn; 1981 Aug; 66(2):133-41. PubMed ID: 7033936
    [No Abstract]   [Full Text] [Related]  

  • 12. In vitro characterization of T and B lymphocytes in chronic lymphatic leukemia and Hodgkin's disease.
    Tursi A; Ferrannini A; Losito G
    Boll Ist Sieroter Milan; 1974; 53(1):suppl:306. PubMed ID: 4604590
    [No Abstract]   [Full Text] [Related]  

  • 13. Impaired autologous mixed lymphocyte reactivity in Hodgkin's disease.
    Begemann M; Claas G; Falke H
    Klin Wochenschr; 1982 Jan; 60(1):19-26. PubMed ID: 6210797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Inhibitory action of Hodgkin's disease patients serum on T lymphocytes E rosette forming ability (author's transl)].
    Panteghini M; Piccioli E; Migliorati T; Ruggeri G
    Ann Sclavo; 1979; 21(4):483-93. PubMed ID: 317987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concanavalin A-induced suppressor cell activity in Hodgkin's disease.
    Schulof RS; Lee BJ; Lacher MJ; Straus DJ; Clarkson BD; Good RA; Gupta S
    Clin Immunol Immunopathol; 1980 Aug; 16(4):454-62. PubMed ID: 6447556
    [No Abstract]   [Full Text] [Related]  

  • 16. Management of advanced Hodgkin's disease in remission.
    Klener P; Hausner P; Donner L
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(2):213-7. PubMed ID: 6179821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunolical aspects of diagnosis and pathogenesis of lymphogranulomatosis].
    Iarilin AA
    Med Radiol (Mosk); 1976 Oct; 21(10):18-22. PubMed ID: 799739
    [No Abstract]   [Full Text] [Related]  

  • 18. Interference of levamisole with inhibition of E-rosette formation by Hodgkin's disease and systemic lupus erythematosus cytotoxic sera.
    Del Giacco GS; Tognella S; Leone AL; Locci F; Cornaglia P; Sangiuolo A; Grifoni V
    Blood; 1979 May; 53(5):1002-6. PubMed ID: 435634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Nonspecific immunologic response in Hodgkin's disease].
    Rytwiński K; Schneiberg K; Szelc S; Kołosza Z; Tabeńska J
    Nowotwory; 1981; 31(3-4):181-90. PubMed ID: 6979738
    [No Abstract]   [Full Text] [Related]  

  • 20. [Immunity and hypersensitivity in Hodgkin's lymphoma].
    Leoni P; Marchegiani G; Montillo M; Centurioni R; Montroni M; Danieli G
    Minerva Med; 1982 May; 73(20):1361-9. PubMed ID: 6210855
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.